Strategic Board Advisor & Investor - N21.ai

Join the inner circle of accredited investors and strategic advisors for N21.AI — a biotech + AI-driven startup building next-gen diagnostic and therapeutic platforms. N21.AI seeks experienced physicians, biotech executives, strategic thinkers, and accredited investors who want hands-on early access. Members of this circle serve both as advisors shaping direction and early backers positioned to benefit as N21.AI scales. This structure — combining advisory insight + early investment option — offers a rare alignment: you guide value creation and share in upside from that early ground floor.What’s Going On at N21.AI (Stealth Mode – Early Traction Underway)• Founding team includes seasoned biotech & AI engineers with multiple prior exits and top-tier credentials. • Early internal milestones achieved: proof-of-concept in diagnostic AI module; data-pipeline infrastructure built; early outreach to clinical partners underway. • Raised seed capital from private network (non-dilutive grants + founder capital), enabling core development without aggressive dilution or external pressure. • Patent filings & IP preparations under way — positioning N21.AI to enter regulatory/clinical stages within 12–18 months.What Accredited Advisors Receive (If Selected)• Private Strategy Briefings with N21.AI’s founder & core team• Early-Access to Deal Materials — including pipeline roadmap, product demos, and future funding plans• Invitation to Strategic Advisory Board — contribute to go-to-market, regulatory strategy, clinical partnerships, or product design• Optional Investor Slot — early access to raise (e.g., $25,000+) when the next round opens; ability to invest via personal funds or rollover-eligible IRAs/401(k)s (if applicable)• Priority Access to Founder Dinners / Small-Group Sessions — meet other early investors, network, and stay aligned on growthWhoThis Is For• Experienced healthcare professionals: physicians, scientists, regulatory, biotech operations• Accredited investors with interest in biotech, AI, diagnostics, or frontier medical technologies• Strategic operators, entrepreneurs, or advisors who understand regulatory cycles and value early positioning• Individuals comfortable with early-stage risk for high asymmetric upside/ Get More Info• Submit interest via Invest Concierge (LinkedIn or official submission form)• Initial screening to confirm accreditation and background fit• NDA → Introductory call / virtual briefing with founder and core team• If aligned → Invitation to advisory-investor circle; receive deal materials + early accessNo public offering, no public solicitation.This is a private, curated offering for qualified individuals. Why We’re Doing ItThis WayN21.AI is in a foundational stage — building diagnostic & therapeutic infrastructure, securing IP, and preparing for clinical/market entry. We believe that having strategic advisors who also invest aligns incentives: you help us build right, early; you benefit if we succeed. Because we are still early and steering carefully, this invitation-only model protects confidentiality, ensures quality, and aligns long-term vision for both founders and early supporters.If you are interested in shaping the future of biotech + AI and want early access to a high-potential startup — we welcome your inquiry. Apply tot his job